Quotes 5-day view Delayed Xetra
06/02/2023
06/05/2023
06/06/2023
06/07/2023
06/08/2023
Date
52.61(c)
52.12(c)
52.28(c)
52.13(c)
51.95
Last
2 111 109
1 440 425
1 234 632
1 121 647
1 150 651
Volume
+1.37%
-0.93%
+0.31%
-0.29%
-0.35%
Change
Estimated financial data (e) EUR USD
Sales 2023
50 060 M
53 591 M
53 591 M
Net income 2023
4 205 M
4 502 M
4 502 M
Net Debt 2023
32 925 M
35 248 M
35 248 M
P/E ratio 2023
11,9x
Yield 2023
4,61%
Sales 2024
51 301 M
54 920 M
54 920 M
Net income 2024
5 201 M
5 568 M
5 568 M
Net Debt 2024
30 148 M
32 275 M
32 275 M
P/E ratio 2024
9,98x
Yield 2024
4,89%
Capitalization
51 214 M
54 827 M
54 827 M
EV / Sales 2023
1,68x
EV / Sales 2024
1,59x
Nbr of Employees
101 735
Free-Float
100,0%
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows:
- agrochemicals (49.6%): herbicides, fungicides, insecticides, etc.;
- pharmaceutical products (37.9%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.;
- OTC...
News in other languages on BAYER AG
Analyst Recommendations on BAYER AG
ETFs positioned on BAYER AG ETFs and Trackers with Trackinsight
U.S. Supreme Court spurns dispute over Monsanto class-action settlement
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends BAYER AG
Short Term Mid-Term Long Term Trends Bearish Neutral Neutral
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
BUY
Number of Analysts
21
Last Close Price
52,13 €
Average target price
73,29 €
Spread / Average Target
40,6%
Please enable JavaScript in your browser's settings to use dynamic charts.